大血管闭塞直接取栓与桥接治疗的临床与神经影像结局:SELECT队列分析
基于SELECT前瞻性多中心队列,纳入前循环大血管闭塞且发病4.5小时内到院的226例患者,比较直接取栓与桥接治疗。桥接治疗与更高的90天功能独立率和更低的90天死亡率相关,亚组分析显示基线NIHSS<15和核心梗死体积<50 cm³的患者获益更明显。
要点
- 桥接治疗与更高90天功能独立率相关(57% vs 44%,aOR 2.02,95%CI 1.01-4.03,p=0.046)。
- 桥接治疗与更低90天死亡率相关(11% vs 23%,aOR 0.20,95%CI 0.07-0.58,p=0.003)。
- 基线NIHSS<15患者桥接治疗功能独立获益更明显(aOR 4.87,95%CI 1.56-15.18,p=0.006)。
核心结论
- 桥接治疗似乎与更好的临床结局相关,尤其在NIHSS评分较轻、核心梗死体积较小和转诊患者中。
- 在卒中更严重的患者中未观察到桥接治疗的潜在获益。
研究设计与样本
- SELECT为前瞻性多中心队列研究,评估影像选择用于血管内取栓。
- 纳入前循环大血管闭塞且发病4.5小时内到取栓中心医院的226例患者,比较桥接治疗与直接取栓。
主要发现
- 桥接治疗组90天功能独立率57%,直接取栓组44%(aOR 2.02,95%CI 1.01-4.03,p=0.046)。
- 桥接治疗组90天死亡率11%,直接取栓组23%(aOR 0.20,95%CI 0.07-0.58,p=0.003)。
- 桥接治疗与功能改善相关(调整共同OR 2.06,95%CI 1.18-3.60,p=0.011)。
- 基线NIHSS<15患者桥接治疗功能独立aOR 4.87(95%CI 1.56-15.18,p=0.006),NIHSS≥15患者aOR 1.05(95%CI 0.40-2.74,p=0.92)。
- 核心梗死体积<50 cm³患者桥接治疗功能改善aOR 2.10(95%CI 1.02-4.33,p=0.044),≥50 cm³患者aOR 0.41(95%CI 0.01-16.02,p=0.64)。
关键数值与推荐
- 主要结局为90天功能独立(mRS评分0-2)。
- 次要结局包括90天mRS等级变化、死亡率和症状性颅内出血。
临床怎么用
- 对于前循环大血管闭塞且发病4.5小时内到院的患者,桥接治疗可能带来更好的90天功能结局。
- 桥接治疗的获益在NIHSS评分较轻和核心梗死体积较小的患者中更明显。
局限性
- 本研究提供Class III证据。
- 部分亚组分析置信区间较宽,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the comparative safety and efficacy of direct endovascular thrombectomy (dEVT) compared to bridging therapy (BT; IV tissue plasminogen activator + EVT) and to assess whether BT potential benefit relates to stroke severity, size, and initial presentation to EVT vs non-EVT center. METHODS: In a prospective multicenter cohort study of imaging selection for endovascular thrombectomy (Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke [SELECT]), patients with anterior circulation large vessel occlusion (LVO) presenting to EVT-capable centers within 4.5 hours from last known well were stratified into BT vs dEVT. The primary outcome was 90-day functional independence (modified Rankin Scale [mRS] score 0-2). Secondary outcomes included a shift across 90-day mRS grades, mortality, and symptomatic intracranial hemorrhage. We also performed subgroup analyses according to initial presentation to EVT-capable center (direct vs transfer), stroke severity, and baseline infarct core volume. RESULTS: We identified 226 LVOs (54% men, mean age 65.6 ± 14.6 years, median NIH Stroke Scale [NIHSS] score 17, 28% received dEVT). Median time from arrival to groin puncture did not differ in patients with BT when presenting directly (dEVT 1.43 [interquartile range (IQR) 1.13-1.90] hours vs BT 1.58 [IQR 1.27-2.02] hours, p = 0.40) or transferred to EVT-capable centers (dEVT 1.17 [IQR 0.90-1.48] hours vs BT 1.27 [IQR 0.97-1.87] hours, p = 0.24). BT was associated with higher odds of 90-day functional independence (57% vs 44%, adjusted odds ratio [aOR] 2.02, 95% confidence interval [CI] 1.01-4.03, p = 0.046) and functional improvement (adjusted common OR 2.06, 95% CI 1.18-3.60, p = 0.011) and lower likelihood of 90-day mortality (11% vs 23%, aOR 0.20, 95% CI 0.07-0.58, p = 0.003). No differences in any other outcomes were detected. In subgroup analyses, patients with BT with baseline NIHSS scores <15 had higher functional independence likelihood compared to those with dEVT (aOR 4.87, 95% CI 1.56-15.18, p = 0.006); this association was not evident for patients with NIHSS scores ≥15 (aOR 1.05, 95% CI 0.40-2.74, p = 0.92). Similarly, functional outcomes improvements with BT were detected in patients with core volume strata (ischemic core <50 cm3: aOR 2.10, 95% CI 1.02-4.33, p = 0.044 vs ischemic core ≥50 cm3: aOR 0.41, 95% CI 0.01-16.02, p = 0.64) and transfer status (transferred: aOR 2.21, 95% CI 0.93-9.65, p = 0.29 vs direct to EVT center: aOR 1.84, 95% CI 0.80-4.23, p = 0.15). CONCLUSIONS: BT appears to be associated with better clinical outcomes, especially with milder NIHSS scores, smaller presentation core volumes, and those who were "dripped and shipped." We did not observe any potential benefit of BT in patients with more severe strokes. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT02446587. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with ischemic stroke from anterior circulation LVO within 4.5 hours from last known well, BT compared to dEVT leads to better 90-day functional outcomes.
引用
- Sarraj A, Grotta J, Albers GW, et al. Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion: Analysis of the SELECT Cohort Study. Neurology. 2021. PMID: 33875560. doi:10.1212/WNL.0000000000012063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。